formaldehyde has been researched along with a-317491 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchi, B; Faltynek, CR; Honore, P; Jarvis, MF; McDonald, HA; McGaraughty, S; Mikusa, J; Wismer, CT; Zhu, CZ | 1 |
| Fukui, M; Kaneko, S; Minami, M; Nakagawa, T; Satoh, M | 1 |
| Chen, SS; Fang, HZ; Liu, PF; Yang, Y; Zhang, LC; Zhang, QQ; Zhou, F; Zhou, QQ | 1 |
3 other study(ies) available for formaldehyde and a-317491
| Article | Year |
|---|---|
Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
Topics: Analgesia; Animals; Arthritis, Experimental; Dose-Response Relationship, Drug; Endorphins; Formaldehyde; Freund's Adjuvant; Inflammation; Injections, Spinal; Ligation; Male; Naloxone; Narcotic Antagonists; Pain; Peripheral Nervous System Diseases; Phenols; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3; Suramin | 2005 |
Inhibitory role of supraspinal P2X3/P2X2/3 subtypes on nociception in rats.
Topics: Acetic Acid; Adenosine Triphosphate; Analgesics; Animals; Dose-Response Relationship, Drug; Formaldehyde; Male; Pain; Pain Measurement; Phenols; Polycyclic Compounds; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3 | 2006 |
Activation of P2X3 receptors in the cerebrospinal fluid-contacting nucleus neurons reduces formalin-induced pain behavior via PAG in a rat model.
Topics: Adenosine Triphosphate; Animals; Cerebrospinal Fluid; Cholera Toxin; Disease Models, Animal; Disinfectants; Formaldehyde; Injections, Intraventricular; Male; Neurons; Pain; Pain Measurement; Pain Threshold; Periaqueductal Gray; Phenols; Polycyclic Compounds; Purinergic P2X Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X3; Ribosome Inactivating Proteins, Type 1; Saporins | 2017 |